P. Wen and S. Kesari, Malignant Gliomas in Adults, New England Journal of Medicine, vol.359, issue.5, pp.492-507, 2008.
DOI : 10.1056/NEJMra0708126

M. De-tayrac, A. Etcheverry, M. Aubry, S. Saikali, A. Hamlat et al., Integrative genome-wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression, Genes, Chromosomes and Cancer, vol.58, issue.1, pp.55-68, 2009.
DOI : 10.1002/gcc.20618
URL : https://hal.archives-ouvertes.fr/inserm-00352960

J. Nigro, A. Misra, L. Zhang, I. Smirnov, H. Colman et al., Integrated Array-Comparative Genomic Hybridization and Expression Array Profiles Identify Clinically Relevant Molecular Subtypes of Glioblastoma, Cancer Research, vol.65, issue.5, pp.1678-1686, 2005.
DOI : 10.1158/0008-5472.CAN-04-2921

J. Herman and S. Baylin, Gene Silencing in Cancer in Association with Promoter Hypermethylation, New England Journal of Medicine, vol.349, issue.21, pp.2042-2054, 2003.
DOI : 10.1056/NEJMra023075

A. Karpf and S. Matsui, Genetic Disruption of Cytosine DNA Methyltransferase Enzymes Induces Chromosomal Instability in Human Cancer Cells, Cancer Research, vol.65, issue.19, pp.8635-8639, 2005.
DOI : 10.1158/0008-5472.CAN-05-1961

G. Garcia-manero, Demethylating agents in myeloid malignancies, Current Opinion in Oncology, vol.20, issue.6, pp.705-710, 2008.
DOI : 10.1097/CCO.0b013e328313699c

G. Mack, Epigenetic Cancer Therapy Makes Headway, JNCI Journal of the National Cancer Institute, vol.98, issue.20, pp.1443-1444, 2006.
DOI : 10.1093/jnci/djj447

T. Watanabe, H. Yokoo, M. Yokoo, Y. Yonekawa, P. Kleihues et al., Concurrent Inactivation of RB1 and TP53 Pathways in Anaplastic Oligodendrogliomas, Journal of Neuropathology & Experimental Neurology, vol.60, issue.12, pp.1181-1189, 2001.
DOI : 10.1093/jnen/60.12.1181

M. Nakamura, Y. Yonekawa, P. Kleihues, and H. Ohgaki, Promoter Hypermethylation of the RB1 Gene in Glioblastomas, Laboratory Investigation, vol.54, issue.1, pp.77-82, 2001.
DOI : 10.1054/bjoc.1999.0980

J. Costello, M. Berger, H. Huang, and W. Cavenee, Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation, Cancer Res, vol.56, pp.2405-2410, 1996.

M. Bello and J. Rey, The p53/Mdm2/p14ARF cell cycle control pathway genes may be inactivated by genetic and epigenetic mechanisms in gliomas, Cancer Genetics and Cytogenetics, vol.164, issue.2, pp.172-173, 2006.
DOI : 10.1016/j.cancergencyto.2005.07.002

V. Amatya, U. Naumann, M. Weller, and H. Ohgaki, TP53 promoter methylation in human gliomas, Acta Neuropathologica, vol.21, issue.2, pp.178-184, 2005.
DOI : 10.1007/s00401-005-1041-5

R. Stupp, M. Hegi, W. Mason, M. Van-den-bent, M. Taphoorn et al., Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, The Lancet Oncology, vol.10, issue.5, pp.459-466, 2009.
DOI : 10.1016/S1470-2045(09)70025-7

T. Gorlia, M. Van-den-bent, M. Hegi, R. Mirimanoff, M. Weller et al., Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3, The Lancet Oncology, vol.9, issue.1, pp.26981-2298129, 2008.
DOI : 10.1016/S1470-2045(07)70384-4

I. Keshet, Y. Schlesinger, S. Farkash, R. E. Hecht, M. Segal et al., Evidence for an instructive mechanism of de novo methylation in cancer cells, Nature Genetics, vol.394, issue.2, pp.149-153, 2006.
DOI : 10.1038/ng1719

T. Lee, R. Jenner, L. Boyer, M. Guenther, S. Levine et al., Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells, Cell, vol.125, issue.2, pp.301-313, 2006.
DOI : 10.1016/j.cell.2006.02.043

T. Kim, S. Zhong, C. Fields, J. Kim, and K. Robertson, Epigenomic Profiling Reveals Novel and Frequent Targets of Aberrant DNA Methylation-Mediated Silencing in Malignant Glioma, Cancer Research, vol.66, issue.15, pp.7490-7501, 2006.
DOI : 10.1158/0008-5472.CAN-05-4552

G. Foltz, J. Yoon, H. Lee, T. Ryken, Z. Sibenaller et al., DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis, Oncogene, vol.2, issue.29, pp.2667-2677, 2009.
DOI : 10.1007/s10350-007-0286-6

X. Wu, T. Rauch, X. Zhong, W. Bennett, F. Latif et al., CpG Island Hypermethylation in Human Astrocytomas, Cancer Research, vol.70, issue.7, pp.2718-2727, 2010.
DOI : 10.1158/0008-5472.CAN-09-3631

R. Martinez, J. Martin-subero, V. Rohde, M. Kirsch, M. Alaminos et al., A microarray-based DNA methylation study of glioblastoma multiforme, Epigenetics, vol.4, issue.4, pp.255-264, 2009.
DOI : 10.4161/epi.9130

H. Noushmehr, D. Weisenberger, K. Diefes, H. Phillips, K. Pujara et al., Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma, Cancer Cell, vol.17, issue.5, pp.510-522, 2010.
DOI : 10.1016/j.ccr.2010.03.017
URL : https://hal.archives-ouvertes.fr/hal-01201573

D. Louis, H. Ohgaki, O. Wiestler, W. Cavenee, P. Burger et al., The 2007 WHO Classification of Tumours of the Central Nervous System, Acta Neuropathologica, vol.64, issue.2, pp.97-109, 2007.
DOI : 10.1007/s00401-007-0243-4

M. Kang, M. Kim, J. Oh, Y. Kim, S. Song et al., Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers, International Journal of Cancer, vol.279, issue.2, pp.353-355, 2009.
DOI : 10.1002/ijc.24379

R. Martinez and G. Schackert, Epigenetic Aberrations in Malignant Gliomas: An Open Door Leading to Better Understanding and Treatment, Epigenetics, vol.2, issue.3, pp.147-150, 2007.
DOI : 10.4161/epi.2.3.5049

E. Bulk, B. Sargin, U. Krug, A. Hascher, Y. Jun et al., S100A2 Induces Metastasis in Non-Small Cell Lung Cancer, Clinical Cancer Research, vol.15, issue.1, pp.100-222, 2009.
DOI : 10.1158/1078-0432.CCR-08-0953

M. Tseng, S. Liu, H. Chen, Y. Wu, C. Chiu et al., Serine protease inhibitor (SERPIN) B1 promotes oral cancer cell motility and is over-expressed in invasive oral squamous cell carcinoma, Oral Oncology, vol.45, issue.9, pp.771-776, 2009.
DOI : 10.1016/j.oraloncology.2008.11.013

M. Alaminos, V. Davalos, S. Ropero, F. Setien, M. Paz et al., EMP3, a Myelin-Related Gene Located in the Critical 19q13.3 Region, Is Epigenetically Silenced and Exhibits Features of a Candidate Tumor Suppressor in Glioma and Neuroblastoma, Cancer Research, vol.65, issue.7, pp.2565-2571, 2005.
DOI : 10.1158/0008-5472.CAN-04-4283

P. Kannan-thulasiraman, D. Seachrist, G. Mahabeleshwar, M. Jain, and N. Noy, Fatty acid binding protein 5 and PPAR{beta}/{delta} are critical mediators of EGFR-induced carcinoma cell growth, J Biol Chem, 2010.

T. Miura, T. Nishinaka, and T. Terada, Different functions between human monomeric carbonyl reductase 3 and carbonyl reductase 1, Molecular and Cellular Biochemistry, vol.90, issue.132, pp.113-121, 2008.
DOI : 10.1007/s11010-008-9794-5

K. Takenaka, E. Ogawa, H. Oyanagi, H. Wada, and F. Tanaka, Carbonyl Reductase Expression and Its Clinical Significance in Non-Small-Cell Lung Cancer, Cancer Epidemiology Biomarkers & Prevention, vol.14, issue.8, pp.1972-1975, 2005.
DOI : 10.1158/1055-9965.EPI-05-0060

R. Nagarajan and J. Costello, Epigenetic mechanisms in glioblastoma multiforme, Seminars in Cancer Biology, vol.19, issue.3, pp.188-197, 2009.
DOI : 10.1016/j.semcancer.2009.02.005

K. Quinlan, A. Verger, P. Yaswen, and M. Crossley, Amplification of zinc finger gene 217 (ZNF217) and cancer: When good fingers go bad, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1775, issue.2, pp.333-340, 2007.
DOI : 10.1016/j.bbcan.2007.05.001

M. Banck, S. Li, H. Nishio, C. Wang, A. Beutler et al., The ZNF217 oncogene is a candidate organizer of repressive histone modifiers, Epigenetics, vol.4, issue.2, pp.100-106, 2009.
DOI : 10.4161/epi.4.2.7953

L. Feng, M. Hatten, and N. Heintz, Brain lipid-binding protein (BLBP): A novel signaling system in the developing mammalian CNS, Neuron, vol.12, issue.4, pp.895-908, 1994.
DOI : 10.1016/0896-6273(94)90341-7

G. Kaloshi, K. Mokhtari, C. Carpentier, S. Taillibert, J. Lejeune et al., FABP7 expression in glioblastomas: relation to prognosis, invasion and EGFR status, Journal of Neuro-Oncology, vol.9, issue.3, pp.245-248, 2007.
DOI : 10.1007/s11060-007-9377-4

Y. Jung, J. Park, Y. Bang, and T. Kim, Gene silencing of TSPYL5 mediated by aberrant promoter methylation in gastric cancers, Laboratory Investigation, vol.37, issue.2, pp.153-160, 2008.
DOI : 10.1038/sj.onc.1206774

E. Kim, S. Lee, T. Kim, S. Choi, E. Cho et al., TSPYL5 is involved in cell growth and the resistance to radiation in A549 cells via the regulation of p21WAF1/Cip1 and PTEN/AKT pathway, Biochemical and Biophysical Research Communications, vol.392, issue.3, pp.448-453, 2010.
DOI : 10.1016/j.bbrc.2010.01.045

H. Phillips, S. Kharbanda, R. Chen, W. Forrest, R. Soriano et al., Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis, Cancer Cell, vol.9, issue.3, pp.157-173, 2006.
DOI : 10.1016/j.ccr.2006.02.019

R. Verhaak, K. Hoadley, E. Purdom, V. Wang, Y. Qi et al., Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1, Cancer Cell, vol.17, issue.1, pp.98-110, 2010.
DOI : 10.1016/j.ccr.2009.12.020

R. Stupp, W. Mason, M. Van-den-bent, M. Weller, B. Fisher et al., Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma, New England Journal of Medicine, vol.352, issue.10, pp.987-996, 2005.
DOI : 10.1056/NEJMoa043330

J. Dunn, A. Baborie, F. Alam, K. Joyce, M. Moxham et al., Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy, British Journal of Cancer, vol.33, issue.1, pp.124-131, 2009.
DOI : 10.1097/nen.0b013e31815f65fb

C. Stolt, S. Rehberg, M. Ader, P. Lommes, D. Riethmacher et al., Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10, Genes & Development, vol.16, issue.2, pp.165-170, 2002.
DOI : 10.1101/gad.215802

M. Salvati, A. Formichella, D. Elia, A. Brogna, C. Frati et al., Cerebral glioblastoma with oligodendrogliomal component: analysis of 36 cases, Journal of Neuro-Oncology, vol.6, issue.9, pp.129-134, 2009.
DOI : 10.1007/s11060-009-9815-6